Upper respiratory tract infection (wind heat invasion, excessive lung and stomach heat syndrome)
Conditions
Interventions
Experimental group:Re Yan Ning mixture, oral, 20ml once, 3 times a day
Hot Yanning particle simulator, take with boiling water, 2 bags at a time, 3 times a day
Antiviral particle simulator, take with boiling water, 1 bag at a time, 3 times a day.
Control group of similar positive drugs:Antiviral particles, take with boiling water, 1 bag at a time, 3 times a day
Re Yan Ning mixture simulant, oral, 20ml once, 3 times a day
Hot Yanning particle simulator, take with boiling water, 2 bags at a time, 3 times a day.
Control group of positive drugs of the same variety:Hot Yanning granules, take with boiling water, 2 bags at a time, 3 times a day
Sponsors
Beijing University of Traditional Chinese Medicine Dongzhimen Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Meet the Western diagnostic criteria for upper respiratory tract infection; 2. Meet the traditional Chinese medicine diagnostic criteria for wind heat invasion and excessive lung and stomach heat syndrome; 3. Age between 18 and 70 years old (including boundary values), gender not limited; 4. The course of this illness is within 48 hours; 5.Voluntarily participate in the experiment and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Regular use of other medications for the treatment of this disease within 48 hours prior to this visit; 2. Other causes of rhinitis (such as allergic, seasonal, vasomotor, and drug-induced rhinitis), nasal foreign bodies, or foreign body inhalation, as well as abnormal nasal or sinus structures, should be excluded; 3. Respiratory tract infections such as herpetic angina, acute tonsillitis, tracheitis bronchitis, pneumonia, or bronchial asthma, influenza; 4. Patients with spleen and stomach deficiency and cold are prone to diarrhea; 5. Patients with a body temperature of = 38.5 ? during this visit, or those who require concomitant use of antipyretic and analgesic drugs; 6. Combine patients with severe primary diseases of the heart, cerebrovascular, hematopoietic system, and psychiatric disorders; 7. Abnormal liver and kidney function (ALT, AST>1.5 times the upper limit of normal values); Scr>upper limit of normal value; 8. Pregnant or planned pregnant or lactating women; 9. Individuals with allergic constitution or allergies to all drugs or ingredients in this trial; 10. Candidates who have participated in clinical trials of other drugs/devices within one month prior to screening; 11.Researchers believe that individuals who are not suitable to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease recovery time; | — |
Secondary
| Measure | Time frame |
|---|---|
| Severity score of main symptoms - AUC of time;Start cooling time and complete cooling time;Clinical disease recovery rate;The efficacy of traditional Chinese medicine syndrome/disappearance rate of individual symptoms;Time for disappearance of individual symptoms;Usage of antipyretic and analgesic drugs; | — |
Countries
China
Contacts
Public ContactLishan Zhang
Beijing University of Traditional Chinese Medicine Dongzhimen Hospital
Outcome results
None listed